ID
17232
Description
Effect of Androgen Blockade Therapy on Thymus Function in Older Patients Who Have Undergone Radical Prostatectomy for Localized Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00379119
Lien
https://clinicaltrials.gov/show/NCT00379119
Mots-clés
Versions (1)
- 01/09/2016 01/09/2016 -
Téléchargé le
1 septembre 2016
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY 4.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Eligibility Prostate Cancer NCT00379119
Eligibility Prostate Cancer NCT00379119
- StudyEvent: Eligibility
Description
Inclusion Criteria
Alias
- UMLS CUI-1
- C1512693
Description
androgen blockade therapy (either single-agent luteinizing hormone-releasing hormone or combined androgen blockade)
Type de données
boolean
Alias
- UMLS CUI [1]
- C1518041
- UMLS CUI [2]
- C3495882
Description
rising prostate-specific antigen; no objective evidence of metastatic disease
Type de données
boolean
Alias
- UMLS CUI [1]
- C0201544
- UMLS CUI [2]
- C0027627
Description
Radiotherapy
Type de données
boolean
Alias
- UMLS CUI [1]
- C1522449
Description
androgen blockade therapy
Type de données
boolean
Alias
- UMLS CUI [1]
- C0279492
Description
no metastatic disease by abdominal/pelvic ct scan and whole-body scan
Type de données
boolean
Alias
- UMLS CUI [1,1]
- C0027627
- UMLS CUI [1,2]
- C0203669
- UMLS CUI [2,1]
- C0027627
- UMLS CUI [2,2]
- C1641132
Description
Inclusion Criteria: Patient Characteristics
Alias
- UMLS CUI-1
- C0815172
Description
CT scan
Type de données
boolean
Alias
- UMLS CUI [1]
- C0040405
Description
medical condition affecting the thymus, including myasthenia gravis, lymphoma, hyperthyroidism, or cachexia
Type de données
boolean
Alias
- UMLS CUI [1,1]
- C0012634
- UMLS CUI [1,2]
- C0392760
- UMLS CUI [1,3]
- C0040113
- UMLS CUI [2]
- C0026896
- UMLS CUI [3]
- C0024299
- UMLS CUI [4]
- C0020550
- UMLS CUI [5]
- C0006625
Description
autoimmune disorders
Type de données
boolean
Alias
- UMLS CUI [1]
- C0004364
Description
no acute illness, including active infection
Type de données
boolean
Alias
- UMLS CUI [1]
- C0001314
- UMLS CUI [2]
- C0009450
Description
concurrent therapy
Type de données
boolean
Alias
- UMLS CUI [1]
- C0009429
Description
systemic chemotherapy
Type de données
boolean
Alias
- UMLS CUI [1]
- C1883256
Description
immunological therapy
Type de données
boolean
Alias
- UMLS CUI [1]
- C0021083
Description
antiandrogen
Type de données
boolean
Alias
- UMLS CUI [1]
- C0002842
Description
5-alpha reductase inhibitors, pc-spes, or estrogen-containing nutraceuticals
Type de données
boolean
Alias
- UMLS CUI [1]
- C2936788
- UMLS CUI [2]
- C0756934
- UMLS CUI [3]
- C0014939
Description
systemic steroids
Type de données
boolean
Alias
- UMLS CUI [1]
- C2825233
Similar models
Eligibility Prostate Cancer NCT00379119
- StudyEvent: Eligibility
C3495882 (UMLS CUI [2])
C0027627 (UMLS CUI [2])
C0203669 (UMLS CUI [1,2])
C0027627 (UMLS CUI [2,1])
C1641132 (UMLS CUI [2,2])
C0392760 (UMLS CUI [1,2])
C0040113 (UMLS CUI [1,3])
C0026896 (UMLS CUI [2])
C0024299 (UMLS CUI [3])
C0020550 (UMLS CUI [4])
C0006625 (UMLS CUI [5])
C0009450 (UMLS CUI [2])
C0756934 (UMLS CUI [2])
C0014939 (UMLS CUI [3])